Sean M Amberg

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Antiviral Drug Development. Top assignees: Siga Technologies Inc., Kineta Four, LLC, Kineta Viral Hemorrhagic Fever, LLC. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean M Amberg. Retrieved from https://idiyas.com/inventor/sean-m-amberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 10.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 23(Granted Patents)

Company Filing History:

13 out of 58

Siga Technologies Inc.

Kineta Viral Hemorrhagic Fever, LLC

Years Active: 2011-2018

Loading Chart...

Areas of Expertise:

Arenavirus

Antiviral Drugs

Bacterial Pathogens

Viral Pathogens

Pharmaceutical Compositions

Hemorrhagic Fever

Inhibitors

Sulfonyl Semicarbazides

Semicarbazides

Ureas

Anti-Arenaviral Compounds

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10000486 - Antiviral drugs for treatment of arenavirus infection (2018-06-19),

2. 9968571 - Inhibitors and methods of inhibiting bacterial and viral pathogens (2018-05-15),

3. 9566254 - Inhibitors and methods of inhibiting bacterial and viral pathogens (2017-02-14),

4. 9498470 - Antiviral drugs for treatment of arenavirus infection (2016-11-22),

5. 9233087 - Inhibitors and methods of inhibiting bacterial and viral pathogens (2016-01-12),

6. 9199920 - Antiviral drugs for treatment of arenavirus infection (2015-12-01),

7. 9115065 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses (2015-08-25),

8. 9096597 - Antiviral drugs for treatment of Arenavirus infection (2015-08-04),

9. 8871746 - Antiviral drugs for treatment of arenavirus infection (2014-10-28),

10. 8791110 - Anti-arenaviral compounds (2014-07-29),

11. 8754082 - [object Object] (2014-06-17),

12. 8629170 - Anti-viral drugs for treatment of arenavirus infection (2014-01-14),

13. 8623347 - Antiviral drugs for treatment of arenavirus infection (2014-01-07),

14. 8492434 - Antiviral drugs for treatment of arenavirus infection (2013-07-23),

15. 8461177 - Antiviral drugs for treatment of arenavirus infection (2013-06-11),

Title: Innovator Spotlight - Sean M Amberg: Pioneering Solutions in Antiviral Treatment

Introduction: With a prolific career in inventing groundbreaking solutions in the field of antiviral and antibacterial agents, Sean M Amberg is a trailblazing inventor based in Corvallis, Oregon. His relentless pursuit of innovation has led to numerous patents that have the potential to revolutionize the treatment of viral infections.

Latest Patents: Sean M Amberg's latest patents showcase his expertise in developing antiviral drugs for the treatment of arenavirus infections. These compounds and pharmaceutical compositions offer promising avenues for treating viral infections caused by the Arenavirus family, including Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. Additionally, his work on inhibitors and methods of inhibiting bacterial and viral pathogens highlights his dedication to combatting infectious diseases effectively.

Career Highlights: Throughout his career, Sean M Amberg has made significant contributions while working at renowned companies such as SIGA Technologies Inc. and Kineta Four, LLC. His innovative research and development have garnered recognition for their potential to address pressing global health challenges.

Collaborations: Sean M Amberg has collaborated with esteemed professionals in the field, including Dennis E Hruby and Dongcheng Dai. These collaborations have enriched his work and contributed to the success of his patented inventions.

Conclusion: Sean M Amberg's impactful work in developing antiviral and antibacterial solutions underscores his commitment to advancing healthcare through innovation. His patents not only represent significant scientific achievements but also offer hope for a future where infectious diseases can be effectively treated. Sean M Amberg's pioneering spirit continues to inspire the world of medical research and innovation.

Profile summary based on public USPTO records.